XTL Biopharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XTLB and other ETFs, options, and stocks.

About XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. 

CEO
Noam Band
CEONoam Band
Employees
11
Employees11
Headquarters
Ramat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded
1993
Founded1993
Employees
11
Employees11

XTLB Key Statistics

Market cap
7.66M
Market cap7.66M
Price-Earnings ratio
-6.90
Price-Earnings ratio-6.90
Dividend yield
Dividend yield
Average volume
23.85K
Average volume23.85K
High today
$0.81
High today$0.81
Low today
$0.7763
Low today$0.7763
Open price
$0.7763
Open price$0.7763
Volume
4.93K
Volume4.93K
52 Week high
$2.57
52 Week high$2.57
52 Week low
$0.762
52 Week low$0.762

Stock Snapshot

XTL Biopharmaceuticals(XTLB) stock is priced at $0.78, giving the company a market capitalization of 7.66M. It carries a P/E multiple of -6.90.

During the trading session on 2025-12-17, XTL Biopharmaceuticals(XTLB) shares reached a daily high of $0.81 and a low of $0.78. At a current price of $0.78, the stock is +0.7% higher than the low and still -3.5% under the high.

Trading volume for XTL Biopharmaceuticals(XTLB) stock has reached 4.93K, versus its average volume of 23.85K.

The stock's 52-week range extends from a low of $0.76 to a high of $2.57.

The stock's 52-week range extends from a low of $0.76 to a high of $2.57.

XTLB News

TipRanks 5d
XTL Biopharmaceuticals Faces Leadership Changes at Social Proxy Subsidiary

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.